Influence of confounding factors on plasma Mid-Regional pro-Adrenomedullin and Mid-Regional pro-A-type Natriuretic Peptide concentrations in healthy individuals

Biomarkers

Volumn 16, Issue 3, 2011, Pages 281-287

  Bhandari, Sanjay S ^a   Davies, J E ^a   Struck, J ^b   Ng, L L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b BRAHMS AG   (Germany)

Author keywords

body mass index; heart failure; mid regional pro A type natriuretic peptide; Mid regional pro adrenomedullin; renal function

Indexed keywords

NATRIURETIC FACTOR; PROADRENOMEDULLIN; PROTEIN MID REGIONAL PRO A NATRIURETIC FACTOR; PROTEIN MID REGIONAL PRO ADRENOMEDULLIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; KIDNEY FUNCTION; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PREDICTION; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADRENOMEDULLIN; AGED; ATRIAL NATRIURETIC FACTOR; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEIN PRECURSORS;

EID: 79955080906     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.553750     Document Type: Article

References (31)

1. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipälä J, Ruskoaho H, Leppäluoto J, Vuolteenaho O. (2004). Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A-and B-type natriuretic peptides. Clin Chem. 50. 1576-1588. (Pubitemid 39121226)
2. Devereux RB, Koren MJ, de Simone G, Okin PM, Kligfeld P. (1993). Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 14 Suppl D:8-15. (Pubitemid 23233994)
3. Dieplinger B, Mueller T, Kollerits B, Struck J, Ritz E, von Eckardstein A, Haltmayer M, Kronenberg F; MMKD Study Group. (2009). Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int 75:408-414.
4. Dolci A, Panteghini M. (2006). Te exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 369:179-187.
5. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T. (2007). Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 13:42-49. (Pubitemid 46343794)
6. Ichiki Y Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. (1994). Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338:6-10.
7. Ishimitsu T, Miyata A, Matsuoka H, Kangawa K. (1998). Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells. Biochem Biophys Res Commun 243:463-470. (Pubitemid 28414047)
8. Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. (2008). Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 51:1857-1864. (Pubitemid 351615250)
9. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL. (2007). Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49:1525-1532. (Pubitemid 46517963)
10. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y Nakamura S, Matsuo H, Eto T. (1993a). Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560. (Pubitemid 23227359)
11. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. (1993b). Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194:720-725. (Pubitemid 23245195)
12. Li Y Jiang C, Wang X, Zhang Y Shibahara S, Takahashi K. (2007). Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. Peptides 28:1129-1143. (Pubitemid 46654447)
13. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD. (2010). Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062-2076.
14. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. (2002). Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-167. (Pubitemid 34764819)
15. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfeld PH, Bloom SR. (1997). Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 82:95-100. (Pubitemid 27021277)
16. Morgenthaler NG, Struck J, Alonso C, Bergmann A. (2005). Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823-1829. (Pubitemid 41368172)
17. Morgenthaler NG, Struck J, Tomas B, Bergmann A. (2004). Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50:234-236. (Pubitemid 38125732)
18. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. (1997). Potent and long-lasting vasodilatory efects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 95:1214-1221. (Pubitemid 27097833)
19. Nomura I, Kato J, Tokashiki M, Kitamura K. (2009). Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity. Regul Pept 158:127-131.
20. Panteghini M. (2010). Cardiac: is this biomarker ready for the prime time? Scand J Clin Lab Invest Suppl 242:66-72.
21. Panteghini M. (2006). Te new defnition of myocardial infarction and the impact of troponin determination on clinical practice. Int J Cardiol 106:298-306. (Pubitemid 41781692)
22. Redfeld MM, Rodehefer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. (2002). Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976-982. (Pubitemid 34994995)
23. Ruskoaho H. (1992). Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 44:479-602.
24. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. (1989). Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367.
25. Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K, Fujita T. (2003). Defciency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 41:1080-1085. (Pubitemid 36548606)
26. Stevens LA, Coresh J, Feldman HI, Greene T, Lash J P Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS. (2007). Evaluation of the modifcation of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 18:2749-2757. (Pubitemid 47531202)
27. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. (1994). Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160-1166. (Pubitemid 24234212)
28. Tygesen K, Alpert JS, White HD, Jafe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfnkel EP, Lopez-Sendon JL, Pais P Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Gof D, Tubaro M, Dudek D, Al-Attar N; Joint ESC/ACCF/AHA/WHF Task Force for the Redefnition of Myocardial Infarction. (2007). Universal defnition of myocardial infarction. Circulation 116:2634-2653.
29. Vesely DL. (2001). Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 51:647-658. (Pubitemid 32800707)
30. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P Bergmann A, Anker SD. (2007). Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol 50:1973-1980. (Pubitemid 350046336)
31. Washimine H, Asada Y, Kitamura K, Ichiki Y Hara S, Yamamoto Y Kangawa K, Sumiyoshi A, Eto T (1995). Immunohistochemical identifcation of adrenomedullin in human, rat, and porcine tissue. Histochem Cell Biol 103:251-254.